Breaking News on Global Pharmaceutical Technology & Manufacturing

On your radar > Globalisation

Globalisation

When national businesses become global operations… With the industry sourcing more raw materials and services from around the world and distributing its products in new markets, companies are adapting their business processes to suit a more complex global operating environment.

Zydus Nycomed API site to start production in December

30-Sep-2010 - Zydus Nycomed expects commercial production at its newly commissioned API plant in Navi Mumbai, India to begin in December 2010.

Chinese cancer drug brings HUYA and Quintiles together

29-Sep-2010 - HUYA Bioscience International will co-develop a new Chinese cancer drug, HBI-8000, with Quintiles for the “benefit of cancer patients globally.”

Venus to supply docetaxel to Thailand

29-Sep-2010 - Venus Remedies is supplying docetaxel to Thailand after a compulsory license was issued to make the drug more affordable.

DSM seeks Asian partners; welcomes J&J Crucell takeover

23-Sep-2010 - DSM aims to keep pace with the rapid evolution of pharmaceutical sector through increased partnering and a focus on Asia.

GSK boosts vaccine and cancer units with tech licenses

23-Sep-2010 - GlaxoSmithKline (GSK) has entered into two unrelated development deals by signing license agreements for Delphi Genetics’ StabyExpress for its vaccine production operations and OncoMethylome Sciences’ DNA methylation specific PCR biomarkers for its cancer immunotherapy programme.

Sun set on helping Taro, after buying controlling stake

23-Sep-2010 - India’s Sun Pharma has finally acquired a controlling stake in Israeli generics firm Taro Pharmaceutical Industries, significantly expanding its manufacturing capacity in North America.

Solvay integration will cost manufacturing jobs, says Abbott

22-Sep-2010 - Abbott Laboratories says it will shed manufacturing jobs as part integration of the pharmaceutical business it bought from Solvay earlier this year.

Intelsius introduces new packaging temp-controlled system

22-Sep-2010 - Intelsius, formerly DGP Group, has introduced Orcatherm to address the increasing pharma industry need for temperature-controlled packaging and regulatory compliant sample transport solutions.

Pfizer to review $1.3bn media account with Aegis Group’s Carat

22-Sep-2010 - Worrying times lie ahead for Pfizer’s advertiser, Aegis Group’s Carat, as the drug giant has decided to review its $1.3bn media account, as the firm is speculated to be slashing its outgoings.

SOCMA calls for greater urgency on US R&D tax credit

20-Sep-2010 - SOCMA CEO predicts reintroduction of rejected permanent R&D tax credit plan and urges Congress to act “sooner rather than later” to support US manufacturers.

US FTC OKs Rx-360 audits

20-Sep-2010 - The US FTC has given a positive advisory opinion to Rx-360’s shared audits and said the programme appears to offer “cognisable cost-saving and safety enhancing features”.

Aspen op income up 20%

16-Sep-2010 - Aspen Pharmacare increased operating profit by 20 per cent to R2.6bn ($368m) in its full year results.

News in brief

DKSH lands Hayashibara drug excipients deal

13-Sep-2010 - Japanese excipient maker Hayashibara will access new markets through expanded deal with long-standing partner DKSH.

News in brief

Abbott eyes $2.5bn Indian sales by 2020

09-Sep-2010 - Abbott completes $2.2bn acquisition of Piramal’s Healthcare Solutions biz and predicts Indian sales of $2.5bn by 2020.

Verayo, SkyeTek join for low-cost RFID authentication

09-Sep-2010 - Verayo and SkyeTek have partnered with GlobalPCCA to provide a low-cost RFID authentication system to fight counterfeits in Africa.

Update

GSK taps Lonza for bio plant knowledge; sells R&D site to Galapagos

08-Sep-2010 - GSK will work with Lonza on the development of a UK biomanufacturing plant as part of a new MAb manufacturing contract announced today.

Exclusive interview

Thermo to add sites in China to fulfil APAC aspirations

07-Sep-2010 - Extension of a production site in Shanghai is a small part of the big aspirations Thermo has for China and Asia Pacific.

Cipla looking at 25% Cipla Medpro investment

07-Sep-2010 - Indian drugmaker Cipla may invest in South Africa’s Cipla Medpro to boost manufacturing capacity and improve access to rapidly expanding African pharmaceutical markets.

Colorcon adds Turkey coating lab to tap regional markets

06-Sep-2010 - Colorcon says proximity to emerging drug manufacturing markets was key driver for new Turkey technical service lab.

Aurobindo supplying AZ with generics for emerging markets

06-Sep-2010 - Aurobindo Pharma is to supply AstraZeneca with solid dosage and sterile generic products for sale in emerging products.

Ranbaxy opens $30m SA plant to meet govt call for India trade boost

02-Sep-2010 - Ranbaxy is latest firm targeting South African growth with a new £30m (€24m) Johannesburg tablet and capsule manufacturing plant.

BI opens ‘Centre of Competence’ opens as part of a €100m China plan

02-Sep-2010 - Boehringer Ingelheim has opened its ‘Centre of Competence’ (CoC) in Shanghai to optimise API and chemical intermediates sourcing in China.

Unilife’s Q4 income down on costs and rev decline

31-Aug-2010 - Syringe maker Unilife said it was hit by falling revenues, costs of US relocation and workforce expansion in Q4, but that significant business progress was made in fiscal 2010.

Changes to India’s pharma imports & exports, visualised

30-Aug-2010 - Proposed changes to compulsory licensing and foreign ownership oversight in India sparked discussion last week. To explore the topic, in-PharmaTechnologist presents interactive charts detailing market changes in the country over the past 15 years.

Contractors poaching regulatory, quality and clinical talent, says ZRG

30-Aug-2010 - ZRG Partners says there was a “fight for talent” in hiring, firing and vacancies in Q2, with the outsourcing and pharmaceutical sectors battling for employees within regulatory, quality and clinical roles.

Spotlight

ICH sends Q11 guidelines to EU, US & Japanese regulators

ICH sends Q11 guidelines to EU, US & Japanese regulators

The ICH has sent its Q11 guidelines on APIs to regulatory bodies in the US, European Union...

in-Pharmatechnologist.com's review of Interphex 2012

in-Pharmatechnologist.com's review of Interphex 2012

in-Pharmatechnologist.com was at Interphex 2012 in New York, US to launch the revamped version of our website and speak...

Effective controls still lacking for continuous processing says Interphex panel

Effective controls still lacking for continuous processing says Interphex panel

Continuous processing is still hamstrung by a lack of control systems and is not ready for specific...

BASF buys omega-3 maker Equateq citing pharma potential

BASF buys omega-3 maker Equateq citing pharma potential

BASF has bought omega-3 fatty acid maker Equateq, citing its pharmaceutical and dietary supplements businesses as key...

EMA outlines manufacturing quality docs for biologics trials

EMA outlines manufacturing quality docs for biologics trials

The EMA has published final guidelines on manufacturing quality documents needed for biologics entering clinical trials.